Hainan Huluwa Pharmaceutical Group Co. Ltd. Class ASSE: 605199

Announcement on Wholly-Owned Subsidiary Obtaining Drug Registration Certificate for Compound Polyethylene Glycol (3350) Electrolyte Oral Solution

· Issued by Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Wholly-Owned Subsidiary Obtaining Drug Registration Certificate for Compound Polyethylene Glycol (3350) Electrolyte Oral Solution

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment